Trial intelligence / Profile preview

Diurnal variation of exogenous peptides in adults with growth hormone deficiency

2010-018586-39Phase 2Completed

Sponsor
Department of Endocrinology and Internal Medicine
Start
May 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, open-label trial of somatropin in adult onset growth hormone deficiency (AGHD) (2 arms), sponsored by Department of Endocrinology and Internal Medicine. Started May 2010; status: completed.

02

Drugs

somatropin
03

Conditions

adult onset growth hormone deficiency (AGHD)

Beyond the preview

Go deeper on 2010-018586-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-018586-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call